Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 11/10/08 → 08/26/12 |
Funding
- Hoffmann Laroche Incorporated: $69,091.14
A Phase III, Double-Blind, Randomized Placebo-Controlled Study, to Evaluate the Effects of RO4607381 on Cardiovascular (CV) Risk In Stable CHD Patients, with a Documented recent Acute Coronary Syndrome (ACS)
- Lawson, William (CoPI)
- Gruberg, Luis (PI)
- Brown, David (CoPI)
- Chernilas, Joseph (CoPI)
- Jeremias, Allen (CoPI)
- Mani, Anil (CoPI)
Project: Research